KalVista Pharmaceuticals Files 8-K on Financials
Ticker: KALV · Form: 8-K · Filed: Jul 10, 2025 · CIK: 1348911
| Field | Detail |
|---|---|
| Company | Kalvista Pharmaceuticals, Inc. (KALV) |
| Form Type | 8-K |
| Filed Date | Jul 10, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, operations, sec-filing
Related Tickers: KALV
TL;DR
KalVista dropped an 8-K on July 10th about their financials - check it for the latest.
AI Summary
On July 10, 2025, KalVista Pharmaceuticals, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as financial statements and exhibits. No specific financial figures or operational updates were detailed in the provided excerpt.
Why It Matters
This 8-K filing indicates KalVista Pharmaceuticals is providing updates on its financial condition and operations to the SEC, which is important for investors to monitor company performance.
Risk Assessment
Risk Level: low — The filing is a standard 8-K reporting financial condition and operations, without immediate news of significant events.
Key Players & Entities
- KalVista Pharmaceuticals, Inc. (company) — Registrant
- July 10, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 001-36830 (identifier) — Commission File Number
- 20-0915291 (identifier) — IRS Employer Identification No.
- 55 Cambridge Parkway, Suite 901E, Cambridge, MA 02142 (address) — Business and Mail Address
- Carbylan Therapeutics, Inc. (company) — Former Company Name
- Carbylan Biosurgery, Inc (company) — Former Company Name
FAQ
What specific financial information is being reported in this 8-K filing?
The filing indicates it concerns 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits', but the provided excerpt does not detail specific financial figures.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on July 10, 2025.
What is KalVista Pharmaceuticals, Inc.'s state of incorporation?
KalVista Pharmaceuticals, Inc. is incorporated in Delaware.
What are the former names of KalVista Pharmaceuticals, Inc. mentioned in the filing?
The filing mentions former names of Carbylan Therapeutics, Inc. and Carbylan Biosurgery, Inc.
What is the business address of KalVista Pharmaceuticals, Inc.?
The business address is 55 Cambridge Parkway, Suite 901E, Cambridge, MA 02142.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 10, 2025 regarding KalVista Pharmaceuticals, Inc. (KALV).